The FDA will be relatively stringent on the clinical data because there is no preclinical model for fibromyalgia.
Do you know of any examples of such drugs that were rejected with one good trial and one "just missed"? The only one I can think of is the imaging company but they are far from clear about what it is that they are measuring.
Market Data 
Markets 
AI
